Form 4: Carlyle Group Sells Additional Shares of QuidelOrtho Corp (QDEL)

The Carlyle Group continues to reduce its stake in QuidelOrtho Corp, selling shares through a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group Inc. and affiliated entities have sold shares of QuidelOrtho Corp (QDEL) on June 14 and June 17, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• The transactions involved multiple sales at varying prices, with weighted average prices reported for each day's transactions.
• The total number of indirectly held shares decreased from approximately 12,229,399 to 12,024,063.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document reports routine transactions under a pre-arranged trading plan. The impact on the stock is uncertain but not inherently negative.

Negatives

• The Carlyle Group is reducing its stake in QuidelOrtho, which could be interpreted negatively by the market.

Risks

• Continued sales by Carlyle could put downward pressure on QuidelOrtho's stock price.
• The market may react negatively to the ongoing reduction in Carlyle's ownership.

Future Outlook

The document does not provide specific forward-looking statements, but it indicates continued sales under the Rule 10b5-1 trading plan.

Industry Context

Share sales by major holders like Carlyle Group are common and can be part of portfolio management strategies. The impact on QuidelOrtho's stock will depend on market perception and overall investor sentiment.

Comparison to Industry Standards

• It's common for large shareholders, especially private equity firms like Carlyle, to gradually reduce their stakes in companies after a period of ownership.
• The use of a 10b5-1 trading plan is a standard practice to allow insiders and major shareholders to sell shares without being accused of trading on non-public information.
• Comparable transactions would include similar stake reductions by private equity firms in publicly listed healthcare companies.

Stakeholder Impact

• Shareholders may be concerned about the continued selling pressure from Carlyle Group.
• The company's stock price could be affected by these transactions.

Key Dates